PMID: 32694262DOI: 10.1097/hco.0000000000000774Jul 23, 2020Paper
Sodium-glucose cotransporter 2 inhibitors at the intersection of cardiovascular, renal and metabolic care: an integrated and multidisciplinary approach to patient-centered care.
Current Opinion in Cardiology
Subodh VermaMikhail N Kosiborod
Abstract
The management of individuals who live with type 2 diabetes requires an integrated and multifaceted approach. Sodium-glucose cotransporter 2 inhibitors effectively prevent and treat cardiorenal complications in the presence of type 2 diabetes. They also reduce death and disease progression in those with established heart failure (with reduced ejection fraction) in the absence of diabetes. Close collaborations between primary care physicians, cardiovascular specialists, endocrinologists and nephrologists are necessary to optimize cardiovascular, renal and metabolic risk reduction in their shared patients.
References
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Apr 17, 2008·European Heart Journal·Michael R MacDonaldUNKNOWN CHARM Investigators
Mar 10, 2012·European Journal of Heart Failure·Manuel Martínez-SellésUNKNOWN Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC)
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·John J V McMurrayMarc A Pfeffer
Dec 4, 2014·The Lancet. Diabetes & Endocrinology·Anoop Dinesh ShahHarry Hemingway
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
May 22, 2016·European Heart Journal·Piotr PonikowskiUNKNOWN ESC Scientific Document Group
Jun 15, 2016·Circulation·Cecilia C Low WangAllison B Goldfine
Jun 15, 2016·The New England Journal of Medicine·Christoph WannerUNKNOWN EMPA-REG OUTCOME Investigators
Dec 23, 2016·Clinical Therapeutics·Ronald M GoldenbergJean-François Yale
May 4, 2017·Journal of the American College of Cardiology·Clyde W YancyCheryl Westlake
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Jun 14, 2017·The American Journal of Cardiology·Michael Lehrke, Nikolaus Marx
Nov 15, 2017·Circulation·Subodh VermaBernard Zinman
Mar 10, 2018·European Journal of Heart Failure·Petar M SeferovićJohn J V McMurray
Apr 8, 2018·Diabetes Care·Rasmus RørthJohn J V McMurray
Jun 26, 2018·The Lancet. Diabetes & Endocrinology·Vlado PerkovicBruce Neal
Aug 1, 2018·JACC. Basic to Translational Science·Nikole J ByrneJason R B Dyck
Aug 23, 2018·Diabetologia·Subodh Verma, John J V McMurray
Nov 7, 2018·The Lancet. Diabetes & Endocrinology·Subodh VermaDeepak L Bhatt
Nov 13, 2018·The New England Journal of Medicine·Stephen D WiviottUNKNOWN DECLARE–TIMI 58 Investigators
Nov 13, 2018·JAMA : the Journal of the American Medical Association·Julio RosenstockUNKNOWN CARMELINA Investigators
Nov 15, 2018·Lancet·Subodh VermaC David Mazer
Nov 15, 2018·Lancet·Thomas A ZelnikerMarc S Sabatine
Nov 21, 2018·JACC. Basic to Translational Science·Subodh VermaGary D Lopaschuk
Dec 6, 2018·Cell Metabolism·Kim A ConnellySubodh Verma
Mar 19, 2019·Circulation·Subodh Verma, John J V McMurray
Apr 17, 2019·The New England Journal of Medicine·Vlado PerkovicUNKNOWN CREDENCE Trial Investigators
Jun 12, 2019·Circulation·Subodh Verma, Deepak L Bhatt
Jun 14, 2019·Lancet·Hertzel C GersteinUNKNOWN REWIND Investigators
Jun 15, 2019·The Lancet. Diabetes & Endocrinology·Ofri MosenzonItamar Raz
Jun 21, 2019·Current Opinion in Cardiology·Subodh VermaJaved Butler
Jul 12, 2019·Circulation·Kenneth W MahaffeyVlado Perkovic
Aug 6, 2019·Progress in Cardiovascular Diseases·Vinay GargKim Connelly
Aug 23, 2019·Circulation·Subodh VermaUNKNOWN EMPA-HEART CardioLink-6 Investigators
Sep 3, 2019·Circulation·David D BergMarc S Sabatine
Sep 4, 2019·Cell Metabolism·David A HessSubodh Verma
Sep 10, 2019·The Lancet. Diabetes & Endocrinology·Brendon L NeuenMeg J Jardine
Sep 10, 2019·European Heart Journal·Francesco CosentinoUNKNOWN ESC Scientific Document Group
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Nov 12, 2019·Circulation·C David MazerSubodh Verma
Nov 19, 2019·Circulation·Felipe A MartinezJohn J V McMurray
Nov 20, 2019·The American Journal of Cardiology·Subodh Verma
Dec 16, 2019·The Canadian Journal of Cardiology·Sean KangPaul W M Fedak
Dec 19, 2019·Cardiovascular Research·Subodh Verma
Dec 21, 2019·Diabetes Care·John B BuseMelanie J Davies
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association
Jan 12, 2020·European Journal of Heart Failure·Javed ButlerSubodh Verma
Mar 12, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Erika OpingariRichard E Gilbert
❮ Previous
Next ❯
Related Concepts
Related Feeds
CV Disorders & Type 2 Diabetes
This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.
Related Papers
The New England Journal of Medicine
Julie R Ingelfinger, Clifford J Rosen
Annals of Translational Medicine
Hidekatsu Yanai
Diabetes Care
Devin AbrahamiLaurent Azoulay
Annals of Translational Medicine
André J Scheen
The American Journal of Cardiology
Mohamed M G MohamedBabikir Kheiri